SMAD4 and colorectal cancer: Voorneveld et al. showed that BMP-mediated regulation of the WNT pathway activity may go in both directions depending on the SMAD4 expression and P53 mutation status in colorectal cancer, where they demonstrated that SMAD4 expression negatively correlates with nuclear β-CATENIN in immunohistochemistry samples of patients [77].